DD284601A5 - Verfahren zur herstellung eines arzneimittels - Google Patents

Verfahren zur herstellung eines arzneimittels Download PDF

Info

Publication number
DD284601A5
DD284601A5 DD89332807A DD33280789A DD284601A5 DD 284601 A5 DD284601 A5 DD 284601A5 DD 89332807 A DD89332807 A DD 89332807A DD 33280789 A DD33280789 A DD 33280789A DD 284601 A5 DD284601 A5 DD 284601A5
Authority
DD
German Democratic Republic
Prior art keywords
mononitrate
glycerol
isosorbide
ism
general formula
Prior art date
Application number
DD89332807A
Other languages
German (de)
English (en)
Inventor
Peter Stoss
Matyas Leitold
Original Assignee
�������@�������@���Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �������@�������@���Kk�� filed Critical �������@�������@���Kk��
Publication of DD284601A5 publication Critical patent/DD284601A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
DD89332807A 1988-09-20 1989-09-19 Verfahren zur herstellung eines arzneimittels DD284601A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3831949A DE3831949A1 (de) 1988-09-20 1988-09-20 Arzneimittel

Publications (1)

Publication Number Publication Date
DD284601A5 true DD284601A5 (de) 1990-11-21

Family

ID=6363342

Family Applications (1)

Application Number Title Priority Date Filing Date
DD89332807A DD284601A5 (de) 1988-09-20 1989-09-19 Verfahren zur herstellung eines arzneimittels

Country Status (15)

Country Link
US (1) US5254570A (fr)
EP (1) EP0361156B1 (fr)
JP (1) JPH0643307B2 (fr)
KR (1) KR900004743A (fr)
AT (1) ATE86487T1 (fr)
CA (1) CA1331568C (fr)
DD (1) DD284601A5 (fr)
DE (2) DE3831949A1 (fr)
DK (1) DK461089A (fr)
ES (1) ES2053892T3 (fr)
FI (1) FI894424L (fr)
HU (1) HUT52384A (fr)
IE (1) IE892992L (fr)
IL (1) IL91638A (fr)
PT (1) PT91736B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8003811B2 (en) 2008-02-07 2011-08-23 Nicox S.A. Nitric oxide donor compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2454807A1 (fr) * 1979-04-25 1980-11-21 Laleuf Sa Expl Laboratoires Nouveau medicament constitue par l'association de dinitrate d'isosorbide et de trinitroglycerine
DE3248548A1 (de) * 1982-12-29 1984-07-05 Heinrich Mack Nachf., 7918 Illertissen Acylderivate von 1,4:3,6-dianhydro-hexiten, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3523544A1 (de) * 1985-07-02 1987-01-15 Bayer Ag Nifedipin kombinationspraeparat
DE3523540A1 (de) * 1985-07-02 1987-01-15 Bayer Ag Dihydropyridin kombinationspraeparat

Also Published As

Publication number Publication date
DE68905278T2 (de) 1993-06-17
ATE86487T1 (de) 1993-03-15
US5254570A (en) 1993-10-19
JPH0643307B2 (ja) 1994-06-08
IL91638A (en) 1994-05-30
PT91736A (pt) 1990-03-30
FI894424A7 (fi) 1990-03-21
HUT52384A (en) 1990-07-28
KR900004743A (ko) 1990-04-12
CA1331568C (fr) 1994-08-23
PT91736B (pt) 1995-05-31
EP0361156A3 (en) 1990-04-18
EP0361156B1 (fr) 1993-03-10
FI894424L (fi) 1990-03-21
DE68905278D1 (de) 1993-04-15
IL91638A0 (en) 1990-04-29
EP0361156A2 (fr) 1990-04-04
DK461089A (da) 1990-03-21
FI894424A0 (fi) 1989-09-19
JPH02160790A (ja) 1990-06-20
IE892992L (en) 1990-03-20
ES2053892T3 (es) 1994-08-01
DE3831949A1 (de) 1990-03-22
DK461089D0 (da) 1989-09-19

Similar Documents

Publication Publication Date Title
DE69432644T2 (de) Kombination eines Angiotensin-II antagonistisch wirkendes Benzimidazols mit ein Diuretikum
DE60122928T2 (de) Therapeutische zusammensetzung von amlodipin und benazepril / benazeprilat
DE3505359A1 (de) Arzneimittel zur behandlung von akuter, myocardialer ischaemie
DE1802394C2 (de) Arzneimittel mit antihypertensiver Wirkung, die [(2,6-Dichlorbenzyliden)-amino]-guanidin oder ein Säureadditionssalz davon enthalten
EP0185210B1 (fr) Utilisation de dérivés dipeptidiques pour la préparation de médicaments pour le traitement des malades atteints de sclérose latérale amyotrophique
EP0169465B1 (fr) Mélange de pyrimido-pyrimidines et d'acide O-acétyl-salicyclique, et/ou de leurs sels pharmacologiquement acceptables et son application
DE3212736A1 (de) Verwendung von dihydropyridinen in arzneimitteln mit salidiuretischer wirkung
US4886820A (en) Dihydropyridine combination product comprising a dihydropyridine compound and a cardioactive nitrate
EP0224810B1 (fr) Préparation antihypertensive contenant un mélange
DE3130912A1 (de) Analgetische arzneimittelkombination
DE3136031C2 (fr)
EP0293714B1 (fr) Combinaisons de produits à action antidépressive
DD284601A5 (de) Verfahren zur herstellung eines arzneimittels
DE3736866A1 (de) Mittel zur behandlung des bluthochdrucks und der herzinsuffizienz
DE2209526C3 (de) Coronartherapeutlkum in Form von Gelatine-BeiBkapseln
EP0013252B1 (fr) Agent de réduction du rythme cardiaque
EP0278467A2 (fr) Utilisation des dérivés d'oxoquinazoline pour le traitement de l'hyperuricémic
DE19515971A1 (de) Kombinationspräparate mit vaskulärer Wirkung
DE2823268C2 (fr)
DE2314387C3 (de) Arzneimittel zur Behandlung bösartiger Neubildungen
DD283931A5 (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von herzrhythmusstoerungen
DE1963223A1 (de) Mittel zur Behandlung von Virusinfektionen
DE2618500A1 (de) Pharmazeutische zubereitung fuer die behandlung von bluthochdruck
DE2532180C2 (de) Verwendung von Etozolin bei der Bekämpfung der Hypertonie
DE2636328A1 (de) Arzneimittel

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee